Bibenzyls

"Bibenzyls" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Compounds with 1,2-diphenylethane. They are structurally like reduced STILBENES.

Descriptor ID

D001632

MeSH Number(s)

D02.455.426.559.389.140.308

D02.455.426.559.389.150.700.075

Concept/Terms

Bibenzyls

Below are MeSH descriptors whose meaning is more general than "Bibenzyls".

Chemicals and Drugs [D]
Organic Chemicals [D02]
Hydrocarbons [D02.455]
Hydrocarbons, Cyclic [D02.455.426]
Hydrocarbons, Aromatic [D02.455.426.559]
Benzene Derivatives [D02.455.426.559.389]
Benzyl Compounds [D02.455.426.559.389.140]
Bibenzyls [D02.455.426.559.389.140.308]
Benzylidene Compounds [D02.455.426.559.389.150]
Stilbenes [D02.455.426.559.389.150.700]
Bibenzyls [D02.455.426.559.389.150.700.075]

Below are MeSH descriptors whose meaning is related to "Bibenzyls".

Below are MeSH descriptors whose meaning is more specific than "Bibenzyls".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Bibenzyls" by people in Harvard Catalyst Profiles by year, and whether "Bibenzyls" was a major or minor topic of these publication.

Bar chart showing 9 publications over 6 distinct years, with a maximum of 2 publications in 2004 and 2014 and 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2004	0	2	2
2005	0	1	1
2014	2	0	2
2016	2	0	2
2017	0	1	1
2019	1	0	1

Below are the most recent publications written about "Bibenzyls" by people in Profiles.

Synthesis and in vitro cytotoxicity evaluation of ß-carboline-combretastatin carboxamides as apoptosis inducing agents: DNA intercalation and topoisomerase-II inhibition. Bioorg Med Chem. 2019 08 01; 27(15):3285-3298.

View in: PubMed
Early Actions of Anti-Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Drugs on Angiogenic Blood Vessels. Am J Pathol. 2017 Oct; 187(10):2337-2347.

View in: PubMed
4,5-Diaryl-3H-1,2-dithiole-3-thiones and related compounds as combretastatin A-4/oltipraz hybrids: Synthesis, molecular modelling and evaluation as antiproliferative agents and inhibitors of tubulin. Eur J Med Chem. 2016 Oct 21; 122:520-529.

View in: PubMed
Ultrasound-promoted two-step synthesis of 3-arylselenylindoles and 3-arylthioindoles as novel combretastatin A-4 analogues. Sci Rep. 2016 Apr 05; 6:23986.

View in: PubMed
Microwave-assisted synthesis and biological evaluation of 3,4-diaryl maleic anhydride/N-substituted maleimide derivatives as combretastatin A-4 analogues. Bioorg Med Chem Lett. 2015 Feb 01; 25(3):631-4.

View in: PubMed
Synthesis and biological evaluation of novel 3,4-diaryl-1,2,5-selenadiazol analogues of combretastatin A-4. Eur J Med Chem. 2014 Nov 24; 87:1-9.

View in: PubMed
Combretastatin A-4 and structurally related triazole analogues induce caspase-3 and reactive oxygen species-dependent cell death in PC12 cells. Eur J Pharmacol. 2013 Mar 05; 703(1-3):25-32.

View in: PubMed
Bibenzyl- and stilbene-core compounds with non-polar linker atom substituents as selective ligands for estrogen receptor beta. Eur J Med Chem. 2009 Sep; 44(9):3412-24.

View in: PubMed
The novel compounds that activate farnesoid X receptor: the diversity of their effects on gene expression. J Pharmacol Sci. 2008 Jul; 107(3):285-94.

View in: PubMed
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature. 2005 Jul 28; 436(7050):568-72.

View in: PubMed

Related Networks

People

Explore

Similar Concepts

Top Journals

Eur J Med Chem
Sci Rep
J Pharmacol Sci
Eur J Pharmacol
Bioorg Med Chem Lett
Bioorg Med Chem
Nature
Nat Biotechnol
FASEB J
Am J Pathol